Poly(ethylene glycol), α-maleimidopropionamide-ω-formyl terminated

Basic Information Description Application Features And Benefits

Catalog Number	ACMA00013962
Molecular Weight	average Mn 3000
MDL Number	MFCD04041031
NACRES	NA.23
Packaging	Packaging 250 mg in glass insert
Quality Level	100
Storage Temperature	−20°C
αEnd	maleimide
ΩEnd	formyl

Description Polyethylene glycol (PEG) compounds contain a polyether unit, commonly expressed as R1-(O-CH2-CH2)n-O-R2. They are generally biocompatible, non-toxic and stable in both organic and aqueous solutions, and so are extensively used in biological applications, as well as nanotechnology and materials research. Proteins with PEG chain modifications and compounds encapsulated in PEG liposomes exhibit a longer half-life in vivo than their non-PEGylated counterparts, a phenomenon known as PEG shielding. Functionalised PEG lipids and phospholipids can be used for protein-PEG conjugation.

Application Difunctionalized PEG used for protein attachment.

Features And Benefits UV polymerizable maleimido group.

Our products and services are for research use only and cannot be used for any clinical purpose.

The Following May Also Be of Interest to You

• 

  Poly(ethylene glycol) [N-(2-maleimidoethyl)carbamoyl]methyl ether 2-(biotinylamino)ethane

  Cat.No. ACMA00013953

• 

  FMOC-PEG5K-Succinimide Butanoate

  Cat.No. ACMA00013964

• 

  Poly(ethylene glycol) methyl ether 2-(dodecylthiocarbonothioylthio)-2-methylpropionate

  Cat.No. ACMA00014004

• 

  Methoxypolyethylene glycol pyrene

  Cat.No. ACMA00014008

• 

  MAL-PEG2000-B-PLA2000

  Cat.No. ACMA00014051

• 

  Poly(ethylene glycol) (N-hydroxysuccinimide 5-pentanoate) ether N'-(3-maleimidopropionyl)aminoethane

  Cat.No. ACM851040943-1